36 35 12 10 4 1 1300 1330 26 10 5 1 1330 1400 26 10 4 1 1400 1430 10 5 1 1400 1430 10 4 1 1430 1530 1 10 5 1 1430 1530 2
10 4 1 1100 1130 EL-1 1 10 4 2 1100 1130 EL-2 2 10 4 2 1500 1530 EL-3 3 2015 10 4 2 1530 1600 EL-4 4 10 4 5 1100 1130 EL-5 5 10 5 2 1100 1130 EL-6 6 2014
10 5 2 1530 1600 EL-7 7 10 5 2 1600 1630 EL-8 8 10 5 5 900 930 EL-9 9 D 10 5 5 930 1000 EL-10 10 10 5 5 1000 1030 EL-11 11 10 5 5 1030 1100EL-12 12
10 5 5 1100 1130 EL-13 13 10 4 1 1330 1400 2013 Vol.34-4 Late preterm infants LPI 34 37 Vol.34-4 10 4 1 900 1100 S1 1 S1-1 85 S1-2 S1-3 Body compositional disorderbcd S1-4 1 2
10 4 5 900 1100 S2 2 ABC S2-1 S2-2 S2-3 S2-4 10 4 5 1400 1600 S3 3 S3-1 S3-2 S3-3 3 EPADHA S3-4
10 5 1 1600 1800S4 4 S4-1 S4-2 S4-3 10 5 5 1400 1600 S5 5 S5-1 S5-2 S5-3 S5-4
10 5 5 1600 1800 S6 6 S6-1 Modified ERAS S6-2 S6-3 S6-4 10 5 2 900 1100DS NTT 10 5 2 1630 1800 PD PD-1 Wilson
PD-2 1 Wilson PD-3 2 Wilson 10 4 5 1600 1800 WS 3 WS-1 WS-2 WS-3 10 5 1 900 1200 FM2014 Up to Date FM-1 FM-2 FM-3
FM-4 NR NR 10 4 2 1600 1800 SS University of Minnesota Evidence-based NutritionResearch on Walnuts and Health SS-1 Dietary Patterns, Food, and NutrientsEvidence-based Research Findings University of Minnesota SS-2 Walnuts Elicit Many Cardiovascular Benefits The Pennsylvania State University SS-3 The PREDIMED StudyChanging the Landscape of Cardiovascular Risk Reduction University of Barcelona SS-4 Evidence in Support of Dietary Recommendations for Cancer Prevention University of Connecticut 10 4 1 1200 1300 LS1 1 10 4 2 1200 1300 LS2 2
10 4 4 1200 1300 LS3 3 NST 10 4 5 1200 1300 LS4 4 10 5 1 1230 1330 LS5 5 10 5 2 1230 1330 LS6 6 10 5 4 1230 1330 LS7 7 EPA 10 5 5 1230 1330 LS8 8 Mg
10 4 2 900 1100 Y-01 1 2 Y-02 Formula 123 456 Y-03 Y-04 12 34 Y-05 QOL 12 Y-06 Y-07 325 50g 1 23 4
Y-08 12 3 Y-09 Y-10 12
10 4 3 920 1000 1 O-001 12 3 O-002 2 12 34 5 O-003 12 O-004 VPP 10 4 3 1000 1110 1 O-005 1 2 O-006 LDL 12 3
O-007 LDL LDL 12 O-008 123 4 O-009 12 O-010 12 O-011 1 234 10 4 3 1500 1600 1 O-012 12 O-013 12 3 4
O-014 12 3 O-015 2 1 123 4 O-016 1 2 O-017 4,5 EPA 123 10 4 3 1600 1700 O-018 O-019 1 2
O-020 2 6 24,000 12 O-021 12 34 O-022 12 O-023 2 AI LH 12 3 10 4 3 1700 1810 1 O-024 O-025 1 2 O-026 1 23
O-027 2 12 34 O-028 12 34 O-029 KAIDEC Study 1 23 4 5 O-030 1 2 10 4 4 900 1010 1 O-031 PES 1MIWA CLINIC 2 O-032 123 O-033 1
O-034 1 1 2 O-035 12 345 O-036 12 34 5 O-037 12 10 4 4 1010 1110 NST O-038 EPA 1 1NST234 56 O-039 123 O-040 1 285
O-041 123 4 O-042 MNA-SF MNA 123 O-043 NR 12 3 4 10 4 4 1500 1610 O-044 O-045 O-046 123 45 6 O-047 1 2
O-048 1 2 O-049 12 3 4 56 O-050 10 4 4 1610 1710 O-051 12 3 O-052 CoQ10- CD C CoQ10 12 O-053 R- - 12 3 O-054
O-055-12 O-056 10 4 4 1710 1810 O-057 O-058 O-059 MS O-060 CKD 12 34 O-061 4 12 O-062 12 345
10 5 3 900 1010 2 O-063 O-064 12 3 O-065 2 O-066 O-067 O-068 go/no-go 123 O-069 123 45
10 5 3 1010 1110 O-070 O-071 O-072 1-Acetoxychavicol acetate O-073 O-074 12 O-075 1 2 10 5 3 1110 1150 O-076 apoa-v 12 O-077 123
O-078 3 12 O-079 10 5 3 1510 1610 3 O-080 2 1 1 2 O-081 12 O-082 4 123 O-083 2012 1 12 O-084 2012 2 12 O-085 NST 1 2
10 5 3 1610 1720 2 O-086 12 O-087 O-088 TM O-089 ApoB-48 Caco-2 O-090 REF-P1 O-091 12 O-092 12 345 10 5 3 1720 1800 2 O-093
O-094 1 2 O-095 12 34 O-096 1 2 10 5 4 900 1010 2 O-097 Bioelectrical Phase Angle O-098 12 O-099 D 1 23 O-100 12 3 O-101 12 34 5
O-102 12 O-103 123 456 78 9 10 5 4 1010 1100 O-104 12 34 5 O-105 12 O-106 123 4 O-107 O-108 hepcidin 1
10 5 4 1100 1200 O-109 12 O-110 7 O-111 1 2 O-112 2 1 23 4 O-113 12 O-114 2 12 3 10 5 4 1510 1610 O-115 3
O-116 O-117 20 12 O-118 REF-P1 123 45 O-119 PEG 12 O-120 10 5 4 1610 1710 O-121 1 234 O-122 12 3 O-123
O-124 Q10 123 O-125 12 O-126 25- D 12 10 5 4 1710 1800 2 O-127 12 O-128 CDK G45 12 O-129 O-130 IgA CRF 12 O-131 12 34